Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Metronidazole hydrochloride |
Is a |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole measurement |
Component |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole adverse reaction |
Causative agent (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole allergy |
Causative agent (attribute) |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metronidazole 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
métronidazole 5 mg/mL, flacon de 20 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
métronidazole 5 mg/mL, sac de 100 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metronidazole 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 1 g rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole+nystatin 400mg/10000units tablet+pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole [vaginal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metronidazole 7.5 milligram/1 gram conventional release vaginal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 7.5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing diloxanide and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole+antifungal (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral metronidazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing metronidazole in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rectal metronidazole (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Topical metronidazole (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 750mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 7.5 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metronidazole 375 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 5mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 0.75% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 100mg infusion solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole benzoate (substance) |
Is a |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing metronidazole and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing bismuth subsalicylate and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cefuroxime and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole and tinidazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 10 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bismuth biskalcitrate + metornidazole + tetracycline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole allergy |
Causative agent (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 250 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 375 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 375 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole benzoate (substance) |
Is modification of (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole hydrochloride |
Is modification of (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole 750mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metronidazole 500 milligram/1 each conventional release rectal suppository (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 500 milligram/1 each conventional release rectal suppository (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing diloxanide and metronidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 375 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 250 mg oral tablet |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 200 mg oral tablet |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 500 mg oral tablet |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole-containing product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 7.5 mg/g cutaneous cream |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 7.5 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 10 mg/g cutaneous cream |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 10 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole (as metronidazole benzoate) 250 milligram/1 gram conventional release dental gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 7.5 milligram/1 gram conventional release vaginal gel (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 7.5 milligram/1 gram conventional release vaginal gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 500 milligram/100 milliliter conventional release solution for infusion bag |
Has precise active ingredient |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 500 milligram/100 milliliter conventional release solution for infusion bag |
Has basis of strength substance (attribute) |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cefuroxime and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bismuth subsalicylate and metronidazole and tetracycline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diloxanide and metronidazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metronidazole and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |